Ranolazin (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Ranolazin" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

12nih.gov

4^th place

13^th place

9doi.org

2^nd place

4^th place

5web.archive.org

1^st place

2tga.gov.au

3,984^th place

4,575^th place

2fda.gov

447^th place

792^nd place

2gilead.com

low place

2semanticscholar.org

11^th place

330^th place

1hres.ca

low place

1drugs.com

399^th place

480^th place

1thefreelibrary.com

518^th place

1,242^nd place

1prnewswire.com

406^th place

1,043^rd place

1thepharmaletter.com

low place

1nytimes.com

7^th place

35^th place

1menariniapac.com

low place

1archive.org

6^th place

2^nd place

1europa.eu

68^th place

182^nd place

1eurekalert.org

3,538^th place

5,808^th place

archive.org (Global: 6^th place; Indonesian: 2^nd place)

Banon D, Filion KB, Budlovsky T, Franck C, Eisenberg MJ (March 2014). "The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials". The American Journal of Cardiology. 113 (6): 1075–1082. doi:10.1016/j.amjcard.2013.11.070. PMID 24462341.

doi.org (Global: 2^nd place; Indonesian: 4^th place)

Banon D, Filion KB, Budlovsky T, Franck C, Eisenberg MJ (March 2014). "The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials". The American Journal of Cardiology. 113 (6): 1075–1082. doi:10.1016/j.amjcard.2013.11.070. PMID 24462341.
Rosa GM, Dorighi U, Ferrero S, Brunacci M, Bertero G, Brunelli C (June 2015). "Ranolazine for the treatment of atrial fibrillation". Expert Opinion on Investigational Drugs. 24 (6): 825–836. doi:10.1517/13543784.2015.1036984. PMID 25872749. S2CID 31659714.
De Vecchis R, Ariano C, Giasi A, Cioppa C (June 2018). "Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis". Minerva Cardioangiologica. 66 (3): 349–359. doi:10.23736/S0026-4725.17.04349-3. PMID 28497941.
Kloner RA, Hines ME, Geunes-Boyer S (November 2013). "Efficacy and safety of ranolazine in patients with chronic stable angina". Postgraduate Medicine. 125 (6): 43–52. doi:10.3810/pgm.2013.11.2711. PMID 24200760. S2CID 2084618.
Noble D, Noble PJ (July 2006). "Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload". Heart. 92 (Suppl 4): iv1 – iv5. doi:10.1136/hrt.2005.078782. PMC 1861316. PMID 16775091.
Sokolov S, Peters CH, Rajamani S, Ruben PC (2013). "Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine". Frontiers in Pharmacology. 4: 78. doi:10.3389/fphar.2013.00078. PMC 3689222. PMID 23801963.
Thomsen MB, Matz J, Volders PG, Vos MA (October 2006). "Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias". Pharmacology & Therapeutics. 112 (1): 150–70. doi:10.1016/j.pharmthera.2005.04.009. PMID 16714061.
Banerjee K, Ghosh RK, Kamatam S, Banerjee A, Gupta A (January 2017). "Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina". International Journal of Cardiology. 227: 556–564. doi:10.1016/j.ijcard.2016.10.102. PMID 27838121.
Redondo-Muñoz M, Rodriguez-Baena FJ, Aldaz P, Caballé-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E, Bocanegra A, Chocarro L, Grier A, Dzieciatkowska MM, Bigas C, Martin J, Urdiroz-Urricelqui U, Marzo F, Santamaria E, Kochan G, Escors D, Larrayoz IM, Heyn H, D'Alessandro A, Attolini CS, Matheu A, Wellbrock C, Benitah SA, Sanchez-Laorden B, Arozarena I (September 2023). "Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy". Nature Metabolism. 5 (9): 1544–1562. doi:10.1038/s42255-023-00861-4. PMC 10513932. PMID 37563469.

drugs.com (Global: 399^th place; Indonesian: 480^th place)

"Ranolazine Monograph for Professionals". Drugs.com (dalam bahasa Inggris). American Society of Health-System Pharmacists. Diakses tanggal 22 March 2019.

eurekalert.org (Global: 3,538^th place; Indonesian: 5,808^th place)

Eureka Alert: Electrical signals between skin cells may influence melanoma initiation

europa.eu (Global: 68^th place; Indonesian: 182^nd place)

ema.europa.eu

EMEA Ranolazine page at the EMEA Diarsipkan 5 October 2016 di Wayback Machine.

fda.gov (Global: 447^th place; Indonesian: 792^nd place)

"Cardiovascular and Renal Drugs Advisory Committee Briefing Document" (PDF). Food and Drug Administration.
"FDA Approves New Treatment for Chest Pain". FDA News. 31 January 2006. Diakses tanggal 2 March 2011.

gilead.com (Global: low place; Indonesian: low place)

"Ranexa (ranolazine) Extended-Release Tablets, for Oral Use. Full Prescribing Information". Gilead Sciences, Inc. Foster City, CA 94404. Diarsipkan dari asli tanggal 7 December 2017. Diakses tanggal 8 September 2016.
"Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results". Gilead. Diarsipkan dari asli tanggal 3 November 2017. Diakses tanggal 1 November 2017.

hres.ca (Global: low place; Indonesian: low place)

hpr-rps.hres.ca

"Summary Basis of Decision (SBD) for Corzyna". Health Canada. 23 October 2014. Diakses tanggal 29 May 2022.

menariniapac.com (Global: low place; Indonesian: low place)

Menarini press release. 18 June 2013 Memarii Group announces agreement with Gilead Sciences to commercialize Ranexa® (ranolazine) in 50 new countries Diarsipkan 7 November 2017 di Wayback Machine.

nih.gov (Global: 4^th place; Indonesian: 13^th place)

pubmed.ncbi.nlm.nih.gov

Banon D, Filion KB, Budlovsky T, Franck C, Eisenberg MJ (March 2014). "The usefulness of ranolazine for the treatment of refractory chronic stable angina pectoris as determined from a systematic review of randomized controlled trials". The American Journal of Cardiology. 113 (6): 1075–1082. doi:10.1016/j.amjcard.2013.11.070. PMID 24462341.
Rosa GM, Dorighi U, Ferrero S, Brunacci M, Bertero G, Brunelli C (June 2015). "Ranolazine for the treatment of atrial fibrillation". Expert Opinion on Investigational Drugs. 24 (6): 825–836. doi:10.1517/13543784.2015.1036984. PMID 25872749. S2CID 31659714.
De Vecchis R, Ariano C, Giasi A, Cioppa C (June 2018). "Antiarrhythmic effects of ranolazine used both alone for prevention of atrial fibrillation and as an add-on to intravenous amiodarone for its pharmacological cardioversion: a meta-analysis". Minerva Cardioangiologica. 66 (3): 349–359. doi:10.23736/S0026-4725.17.04349-3. PMID 28497941.
Kloner RA, Hines ME, Geunes-Boyer S (November 2013). "Efficacy and safety of ranolazine in patients with chronic stable angina". Postgraduate Medicine. 125 (6): 43–52. doi:10.3810/pgm.2013.11.2711. PMID 24200760. S2CID 2084618.
Noble D, Noble PJ (July 2006). "Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload". Heart. 92 (Suppl 4): iv1 – iv5. doi:10.1136/hrt.2005.078782. PMC 1861316. PMID 16775091.
Sokolov S, Peters CH, Rajamani S, Ruben PC (2013). "Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine". Frontiers in Pharmacology. 4: 78. doi:10.3389/fphar.2013.00078. PMC 3689222. PMID 23801963.
Thomsen MB, Matz J, Volders PG, Vos MA (October 2006). "Assessing the proarrhythmic potential of drugs: current status of models and surrogate parameters of torsades de pointes arrhythmias". Pharmacology & Therapeutics. 112 (1): 150–70. doi:10.1016/j.pharmthera.2005.04.009. PMID 16714061.
Banerjee K, Ghosh RK, Kamatam S, Banerjee A, Gupta A (January 2017). "Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina". International Journal of Cardiology. 227: 556–564. doi:10.1016/j.ijcard.2016.10.102. PMID 27838121.
Redondo-Muñoz M, Rodriguez-Baena FJ, Aldaz P, Caballé-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E, Bocanegra A, Chocarro L, Grier A, Dzieciatkowska MM, Bigas C, Martin J, Urdiroz-Urricelqui U, Marzo F, Santamaria E, Kochan G, Escors D, Larrayoz IM, Heyn H, D'Alessandro A, Attolini CS, Matheu A, Wellbrock C, Benitah SA, Sanchez-Laorden B, Arozarena I (September 2023). "Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy". Nature Metabolism. 5 (9): 1544–1562. doi:10.1038/s42255-023-00861-4. PMC 10513932. PMID 37563469.

ncbi.nlm.nih.gov

Noble D, Noble PJ (July 2006). "Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload". Heart. 92 (Suppl 4): iv1 – iv5. doi:10.1136/hrt.2005.078782. PMC 1861316. PMID 16775091.
Sokolov S, Peters CH, Rajamani S, Ruben PC (2013). "Proton-dependent inhibition of the cardiac sodium channel Nav1.5 by ranolazine". Frontiers in Pharmacology. 4: 78. doi:10.3389/fphar.2013.00078. PMC 3689222. PMID 23801963.
Redondo-Muñoz M, Rodriguez-Baena FJ, Aldaz P, Caballé-Mestres A, Moncho-Amor V, Otaegi-Ugartemendia M, Carrasco-Garcia E, Olias-Arjona A, Lasheras-Otero I, Santamaria E, Bocanegra A, Chocarro L, Grier A, Dzieciatkowska MM, Bigas C, Martin J, Urdiroz-Urricelqui U, Marzo F, Santamaria E, Kochan G, Escors D, Larrayoz IM, Heyn H, D'Alessandro A, Attolini CS, Matheu A, Wellbrock C, Benitah SA, Sanchez-Laorden B, Arozarena I (September 2023). "Metabolic rewiring induced by ranolazine improves melanoma responses to targeted therapy and immunotherapy". Nature Metabolism. 5 (9): 1544–1562. doi:10.1038/s42255-023-00861-4. PMC 10513932. PMID 37563469.

nytimes.com (Global: 7^th place; Indonesian: 35^th place)

Reuters, via the New York Times. 12 March 2009. Gilead, a White Knight, to Buy CV Therapeutics

prnewswire.com (Global: 406^th place; Indonesian: 1,043^rd place)

CV Therapeutics, 22 June 2006 CV Therapeutics Acquires Rights to Ranolazine in Asia

semanticscholar.org (Global: 11^th place; Indonesian: 330^th place)

api.semanticscholar.org

Rosa GM, Dorighi U, Ferrero S, Brunacci M, Bertero G, Brunelli C (June 2015). "Ranolazine for the treatment of atrial fibrillation". Expert Opinion on Investigational Drugs. 24 (6): 825–836. doi:10.1517/13543784.2015.1036984. PMID 25872749. S2CID 31659714.
Kloner RA, Hines ME, Geunes-Boyer S (November 2013). "Efficacy and safety of ranolazine in patients with chronic stable angina". Postgraduate Medicine. 125 (6): 43–52. doi:10.3810/pgm.2013.11.2711. PMID 24200760. S2CID 2084618.

tga.gov.au (Global: 3,984^th place; Indonesian: 4,575^th place)

"Prescription medicines: registration of new chemical entities in Australia, 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Diakses tanggal 9 April 2023.
"Prescription medicines and biologicals: TGA annual summary 2017". Therapeutic Goods Administration (TGA). 21 June 2022. Diakses tanggal 31 March 2024.

thefreelibrary.com (Global: 518^th place; Indonesian: 1,242^nd place)

CV Therapeutics press release. 1 April 1996 CV Therapeutics Licenses Late-Stage Anti-Anginal Drug from Syntex (U.S.A.), an Affiliate of Roche Holding Ltd. Diarsipkan 7 November 2017 di Wayback Machine.

thepharmaletter.com (Global: low place; Indonesian: low place)

Thepharmaletter.com 22 September 2008 Italy's Menarini to pay up to $385 million for rights to CV Thera's Ranexa

web.archive.org (Global: 1^st place; Indonesian: 1^st place)

CV Therapeutics press release. 1 April 1996 CV Therapeutics Licenses Late-Stage Anti-Anginal Drug from Syntex (U.S.A.), an Affiliate of Roche Holding Ltd. Diarsipkan 7 November 2017 di Wayback Machine.
Menarini press release. 18 June 2013 Memarii Group announces agreement with Gilead Sciences to commercialize Ranexa® (ranolazine) in 50 new countries Diarsipkan 7 November 2017 di Wayback Machine.
"Ranexa (ranolazine) Extended-Release Tablets, for Oral Use. Full Prescribing Information". Gilead Sciences, Inc. Foster City, CA 94404. Diarsipkan dari asli tanggal 7 December 2017. Diakses tanggal 8 September 2016.
EMEA Ranolazine page at the EMEA Diarsipkan 5 October 2016 di Wayback Machine.
"Gilead Sciences Announces Fourth Quarter and Full Year 2016 Financial Results". Gilead. Diarsipkan dari asli tanggal 3 November 2017. Diakses tanggal 1 November 2017.

Ranolazin (Indonesian Wikipedia)

archive.org (Global: 6th place; Indonesian: 2nd place)

doi.org (Global: 2nd place; Indonesian: 4th place)

drugs.com (Global: 399th place; Indonesian: 480th place)

eurekalert.org (Global: 3,538th place; Indonesian: 5,808th place)

europa.eu (Global: 68th place; Indonesian: 182nd place)

ema.europa.eu

fda.gov (Global: 447th place; Indonesian: 792nd place)

gilead.com (Global: low place; Indonesian: low place)

hres.ca (Global: low place; Indonesian: low place)

hpr-rps.hres.ca

menariniapac.com (Global: low place; Indonesian: low place)

nih.gov (Global: 4th place; Indonesian: 13th place)

pubmed.ncbi.nlm.nih.gov

ncbi.nlm.nih.gov

nytimes.com (Global: 7th place; Indonesian: 35th place)

prnewswire.com (Global: 406th place; Indonesian: 1,043rd place)

semanticscholar.org (Global: 11th place; Indonesian: 330th place)

api.semanticscholar.org

tga.gov.au (Global: 3,984th place; Indonesian: 4,575th place)

thefreelibrary.com (Global: 518th place; Indonesian: 1,242nd place)

thepharmaletter.com (Global: low place; Indonesian: low place)

web.archive.org (Global: 1st place; Indonesian: 1st place)

archive.org (Global: 6^th place; Indonesian: 2^nd place)

doi.org (Global: 2^nd place; Indonesian: 4^th place)

drugs.com (Global: 399^th place; Indonesian: 480^th place)

eurekalert.org (Global: 3,538^th place; Indonesian: 5,808^th place)

europa.eu (Global: 68^th place; Indonesian: 182^nd place)

fda.gov (Global: 447^th place; Indonesian: 792^nd place)

nih.gov (Global: 4^th place; Indonesian: 13^th place)

nytimes.com (Global: 7^th place; Indonesian: 35^th place)

prnewswire.com (Global: 406^th place; Indonesian: 1,043^rd place)

semanticscholar.org (Global: 11^th place; Indonesian: 330^th place)

tga.gov.au (Global: 3,984^th place; Indonesian: 4,575^th place)

thefreelibrary.com (Global: 518^th place; Indonesian: 1,242^nd place)

web.archive.org (Global: 1^st place; Indonesian: 1^st place)